Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lexyfill (hyaluronic acid)
- Development stage
- Unknown
- Lead developer
- HTL Biotechnology
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Subcutaneous
01
Overview
Lexyfill is a hyaluronic acid-based body filler developed by WEDERM Global, specifically designed for aesthetic enhancement and non-surgical body contouring. Composed of cross-linked hyaluronic acid, the product is intended for deep subcutaneous or supraperiosteal injection to provide volume and shape to areas such as the breasts and buttocks, or to correct significant skin depressions. Its mechanism of action is primarily physical; the cross-linked polymer acts as a bulking agent that occupies space within the tissue and recruits water molecules due to its hydrophilic nature, thereby maintaining structural volume and hydration in the treated area. Lexyfill is marketed as a high-viscosity filler to ensure long-lasting results and stability in body applications.
- Brand names
- Lexyfill
- Other names
- Lexyfill Body Filler
02
Targets
CD44 (CD44 antigen)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)RHAMM (Hyaluronan-mediated motility receptor)
Beyond the preview
Go deeper on Lexyfill (hyaluronic acid).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lexyfill (hyaluronic acid).